These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 14993440)

  • 1. Phosphorylation of G protein-coupled receptors: GPCR kinases in heart disease.
    Hata JA; Koch WJ
    Mol Interv; 2003 Aug; 3(5):264-72. PubMed ID: 14993440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic manipulation of myocardial beta-adrenergic receptor activation and desensitization.
    Hata JA; Williams ML; Koch WJ
    J Mol Cell Cardiol; 2004 Jul; 37(1):11-21. PubMed ID: 15242731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiological roles of G-protein-coupled receptor kinases.
    Métayé T; Gibelin H; Perdrisot R; Kraimps JL
    Cell Signal; 2005 Aug; 17(8):917-28. PubMed ID: 15894165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of regulation of G protein-coupled receptor kinases (GRKs) and cardiovascular disease.
    Penela P; Murga C; Ribas C; Tutor AS; Peregrín S; Mayor F
    Cardiovasc Res; 2006 Jan; 69(1):46-56. PubMed ID: 16288730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential functional expression of human myocardial G protein receptor kinases in left ventricular cardiac diseases.
    Dzimiri N; Muiya P; Andres E; Al-Halees Z
    Eur J Pharmacol; 2004 Apr; 489(3):167-77. PubMed ID: 15087239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of GRK2 RH domain-dependent regulation of GPCR coupling to heterotrimeric G proteins.
    Sterne-Marr R; Dhami GK; Tesmer JJ; Ferguson SS
    Methods Enzymol; 2004; 390():310-36. PubMed ID: 15488186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and phenotypic targeting of beta-adrenergic signaling in heart failure.
    Koch WJ
    Mol Cell Biochem; 2004 Aug; 263(1-2):5-9. PubMed ID: 15524162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the role of beta-adrenergic signaling in heart failure?
    Lohse MJ; Engelhardt S; Eschenhagen T
    Circ Res; 2003 Nov; 93(10):896-906. PubMed ID: 14615493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted inhibition of beta-adrenergic receptor kinase-1-associated phosphoinositide-3 kinase activity preserves beta-adrenergic receptor signaling and prolongs survival in heart failure induced by calsequestrin overexpression.
    Perrino C; Naga Prasad SV; Patel M; Wolf MJ; Rockman HA
    J Am Coll Cardiol; 2005 Jun; 45(11):1862-70. PubMed ID: 15936620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of protein kinase C alpha improves myocardial beta-adrenergic receptor signaling and ventricular function in a model of myocardial preservation.
    D'Souza KM; Petrashevskaya NN; Merrill WH; Akhter SA
    J Thorac Cardiovasc Surg; 2008 Jan; 135(1):172-9, 179.e1. PubMed ID: 18179937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial recovery after ischemia and reperfusion injury is significantly impaired in hearts with transgenic overexpression of beta-adrenergic receptor kinase.
    Chen EP; Bittner HB; Akhter SA; Koch WJ; Davis RD
    Circulation; 1998 Nov; 98(19 Suppl):II249-53; discussion II253-4. PubMed ID: 9852910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanisms of regulation and function of G-protein coupled receptor kinases].
    Sobierajska K; Fabczak H; Fabczak S
    Postepy Biochem; 2005; 51(4):421-9. PubMed ID: 16676577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted overexpression of G protein-coupled receptor kinase-2 in osteoblasts promotes bone loss.
    Wang L; Liu S; Quarles LD; Spurney RF
    Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E826-34. PubMed ID: 15585587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gene therapy and benefits in modulating of system beta-adrenergic in cardiac insufficiency].
    Tevaearai HT; Walton GB; Koch WJ
    Rev Med Suisse Romande; 2002 Mar; 122(3):149-53. PubMed ID: 12014253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G protein-coupled receptor kinase 2--a feedback regulator of Gq pathway signalling.
    Theilade J; Haunsø S; Sheikh SP
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):139-51. PubMed ID: 12476795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct beta-adrenergic receptor subtype signaling in the heart and their pathophysiological relevance.
    Zheng M; Han QD; Xiao RP
    Sheng Li Xue Bao; 2004 Feb; 56(1):1-15. PubMed ID: 14985822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of differential modulatory activities of GRK2 and GRK4 on Galphaq-coupled receptor signaling.
    Picascia A; Capobianco L; Iacovelli L; De Blasi A
    Methods Enzymol; 2004; 390():337-53. PubMed ID: 15488187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of betaARK1 restores impaired biochemical beta-adrenergic receptor responsiveness but does not rescue CREB(A133) induced cardiomyopathy.
    Eckhart AD; Fentzke RC; Lepore J; Lang R; Lin H; Lefkowitz RJ; Koch WJ; Leiden JM
    J Mol Cell Cardiol; 2002 Jun; 34(6):669-77. PubMed ID: 12054854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial G protein-coupled receptor kinases: implications for heart failure therapy.
    Iaccarino G; Lefkowitz RJ; Koch WJ
    Proc Assoc Am Physicians; 1999; 111(5):399-405. PubMed ID: 10519160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure.
    Port JD; Bristow MR
    J Mol Cell Cardiol; 2001 May; 33(5):887-905. PubMed ID: 11343413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.